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        The impact of regulatory T cells (T reg cells) 
on HIV disease progression remains unclear. 
T reg cells comprise a heterogeneous collection 
of cells having in common the ability to suppress 
the activation and proliferation of other T cells. 
Because there is evidence that some eff  ector 
T cell responses help to control HIV replication, 
such cells might reasonably be hypothesized 
to be harmful in the setting of HIV infection. 
Typical postacute reduction of plasma viral 
load is coincident with the appearance of adap-
tive T cell responses (  1, 2  ), whereas depletion 
of CD8      T cells (along with NK cells) from 
SIV-infected macaques prevents reduction of 
the viral load below peak or, in the chronic 
phase, leads to a rise in viral load (  3  ). Further-
more, some MHC class I alleles are associated 
with either slow or rapid disease progression; 
these associations have recently been shown to 
be attributable to underlying diff  erences in spe-
cifi  c antiviral CD8      T cell responses (  4  ). Many 
authors have accordingly suggested that inhibi-
tion of antiviral T cell responses by T reg cells 
could lead to viral persistence and more rapid 
disease progression (  5, 6  ). 
  The correlation between the total magni-
tude of the HIV-specifi  c T cell response and 
CD4      T cell count, however, is generally poor 
(  7  ). As a possible explanation for this fi  nding, 
several groups have found that some but not all 
subpopulations of antiviral T cells may be im-
portant for immune control. Betts et al., for 
instance, reported that nonprogressors maintain 
more highly functional HIV-specific CD8      
T cells than do nonprogressors (  8  ). Emu et al. 
demonstrated that controllers of HIV replica-
tion, whether treated or untreated, exhibited 
high levels of HIV-specifi  c CD4      T cells pro-
ducing both IL-2 and IFN-      (  9  ). Both of these 
reports suggest, in essence, that it is the quality 
and not the quantity of the anti-HIV T cell 
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  The impact of regulatory T cells (T reg cells) on the course of HIV and SIV disease is un-
known. T reg cells could suppress protective antiviral responses and accelerate disease 
progression. Alternatively, these cells might block T cell activation and thereby limit viral 
replication as well as activation-associated immunopathology. Given the higher frequency 
of T reg cells known to be present during human fetal ontogeny, such infl  uences may be 
most important in the context of perinatal infection. We found that infant macaques had 
higher fractions of CD4    CD25    CD127  low  FoxP3     T reg cells in the peripheral blood and in 
lymphoid tissues, and that these T reg cells showed greater in vitro suppressive activity on a 
per cell basis. Infant and adult macaques were infected with SIVmac251 to test the infl  u-
ence of the T reg cell compartment on SIV-specifi  c immune responses. After infection with 
SIV, most (three out of four) infant macaques had persistently high viral loads, weak and 
transient SIV-specifi  c CD4     and CD8     T cell responses, and rapid disease progression. T reg 
cells in the infant but not in the adult directly suppressed SIV-specifi  c CD4     T cell re-
sponses, which were detectable only after depletion of T reg cells. In the case of both the 
infant and the adult macaque, T reg cells were not able to directly suppress SIV-specifi  c 
CD8     T cell responses and had no apparent effect on T cell activation. In aggregate, 
these observations suggest that the T reg cell compartment of the infant macaque 
facilitates rapid disease progression, at least in part by incapacitating SIV-specifi  c 
CD4     T cell responses. 2680 T REG CELL SUPPRESSION OF SIV-SPECIFIC CD4      T CELLS | Hartigan-O  ’  Connor et al.
  Elucidation of the impact of T reg cells on lentiviral dis-
ease has been slowed by the diffi   culty of identifying T reg cells 
and the paucity of pharmacologic methods for altering their 
frequency or function. Recently, we reported that the natural 
T reg cells of adult macaques are CD25     FOXP3     CD127  low  , 
as are human T reg cells (  28  ). We report in this paper that 
natural T reg cells are several-fold more abundant in the 
blood and tissues of infant macaques than those of adult 
macaques. We have taken advantage of this naturally occurring, 
age-related diff  erence in T reg cell frequency to study the 
impact of T reg cells on the course of SIV disease, including 
their ability to suppress SIV-specifi  c T cell responses and T 
cell activation. 
    RESULTS   
  Age-dependent differences in the clinical outcome 
of SIV infection 
  Infant and adult macaques were infected intravenously with 
SIVmac251 and followed longitudinally for several months. 
Both age groups exhibited high viral RNA (vRNA) levels 
during the acute phase of infection, although adults attained 
higher peak viral loads in plasma (P = 0.017 for eff  ect of age 
group by two-way analysis of variance [ANOVA];   Fig. 1 A  ).   
A small decrease of plasma vRNA levels was observed be-
tween weeks 2 and 4 after infection in three out of four adult 
macaques, and these animals maintained the resulting set-
point vRNA levels throughout the course of infection (  Fig. 1 A  ). 
The remaining adult was a rapid progressor who maintained 
high viral loads, produced only low levels of anti-SIV anti-
bodies (see below), and had to be killed 18 wk after infection 
because of weight loss and persistent diarrhea. Three out of 
four infant macaques demonstrated only minor declines 
(     0.5 log) in vRNA between weeks 3 and 4 after infection. 
After week 4, these animals experienced progressive accumu-
lation of vRNA in plasma, with an increased level detected 
at nearly every measurement until death. The remaining 
infant (no. 37740, depicted by inverted triangles in   Fig. 1   
and elsewhere) effectively controlled viral replication for 
3 months after infection, after which time vRNA levels 
increased progressively. 
  Consistent with a previous study (  29  ), CD4      T cells de-
creased in all of the adult macaques (  Fig. 1 B  ). In contrast, 
despite similar plasma vRNA levels and the development of 
severe clinical disease requiring death, there was no loss of 
CD4      T cells among infant macaques (  Fig. 1 B  ). In fact, in two 
out of four animals, absolute CD4      T cell numbers increased 
markedly (  Fig. 1 B  ). Analysis of the CD4/CD8 T cell ratio, 
however, revealed a gradual decline (range = 35  –  83%) that 
was more pronounced than the average decline (17%) ob-
served in normal, age-matched infant macaques (  n   = 20) over 
the same time period because of normal T cell development 
(  Fig. 1 C  ). Adult macaques, in comparison, had a decrease 
in the CD4/CD8 T cell ratio that ranged from 60 to 75% 
(unpublished data). Thus, high vRNA levels in infant ma-
caques are not associated with the profound loss of CD4      
T cells that is observed in adult macaques. 
response that is important. Indeed, in lymphocytic chorio-
meningitis infections of mice, it has been shown that antiviral 
CD4      T cell responses are required for the maintenance of 
eff  ective CD8      T cell responses, suggesting that   “  high-quality  ”   
CD4      and CD8      T cell responses could be correlated (  10  ). 
Finally, Kiepiela et al. recently reported that only T cell re-
sponses directed at Gag play a role in immune control during 
chronic HIV infection, whereas responses directed at other 
viral proteins are detrimental (  4  ). It is unknown whether T reg 
cells are capable of inhibiting eff  ective, multifunctional anti-
viral T cell responses or whether T reg cells might diff  eren-
tially aff  ect responses to various viral proteins. 
  Even in the face of robust adaptive immune responses, 
most untreated, HIV-infected patients experience CD4      T 
cell depletion and disease progression. The time to disease 
progression is inversely correlated not only with viral load 
but also with the degree of T cell activation observed in pe-
ripheral blood, as assessed by expression of CD38 on CD8      
T cells (  11  –  13  ). In treated patients, the level of T cell activa-
tion is inversely correlated with treatment-mediated CD4      
T cell gains (  14  ). There are no defi  nitive data demonstrating 
that T cell activation leads to T cell depletion; nevertheless, 
the strength of these associations has provided support for 
the hypothesis that chronic T cell activation is an important 
mechanism of HIV pathogenesis. If this hypothesis is correct, 
then it is possible that T reg cells might retard disease pro-
gression by inhibiting T cell activation. Indeed, Eggena et al. 
found that HIV-infected subjects with higher levels of T cell 
activation harbored a smaller number of T reg cells among 
CD3      cells (  15  ). 
  If T reg cells infl  uence the course of HIV disease, then their 
impact should be most obvious when they are most prevalent. 
Three groups have shown recently that T reg cells are more 
common in fetal human tissue and have proposed that these 
cells contribute to peripheral tolerance in fetal and, perhaps, 
early postnatal life (  16  –  18  ). It is accordingly possible that they 
might have a profound infl  uence, be it positive or negative, in 
the context of perinatal infection. In this regard, it is notable 
that some 20  –  30% of perinatally infected children manifest a 
very rapid pace of disease progression (  19, 20  ). 
  One explanation for faster disease progression among 
some infants is that a lower intensity of adaptive T cell re-
sponses allows for unchecked viral replication. Among infants, 
T helper responses are characterized by lower frequencies 
of antigen-specifi  c T cells (  21  ), a reduced magnitude of the 
response (  22  ), and, often, a Th2 cell bias (  23  ). The lower 
intensity of adaptive T cell responses among infected infants 
might be related to T cell  –  intrinsic defects or to diff  erences 
in the frequency or activity of other immune cells. For ex-
ample, in contrast to adult DCs, infant DCs express lower 
levels of MHC and adhesion molecules (  24, 25  ), their ability 
to produce IL-12 is lower (  26  ), and responses to Toll-like re-
ceptor ligation are reduced because of the limited expression 
of adaptor proteins and the limited activation of downstream 
signaling molecules (  27  ). Therefore, the priming of the T cell 
response to infectious pathogens in infants is compromised. JEM VOL. 204, October 29, 2007 
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  SIV-binding antibody titers were followed throughout 
infection. All animals developed binding antibodies within 
the fi  rst month of infection (  Fig. 1 E  ). Compared with other 
adults, the rapidly progressing animal developed only low an-
tibody titers, as has been observed in similar cases of rapid 
SIV disease progression (  30  ). Infected infants initially devel-
oped antibody responses comparable to those seen in adults. 
In three out of four infants, however, these titers declined 
slowly over the course of infection, in a pattern similar to that 
  A more detailed analysis revealed that infant macaques 
showed some loss of CD4      T cells with an eff  ector/memory 
phenotype, but this loss was masked by the fact that this pop-
ulation represented only a very small fraction in peripheral in-
fant blood (unpublished data). Except for monkey no. 37740, 
who had the lowest plasma vRNA levels, infant macaques 
showed an early loss of activated CC chemokine receptor 
(CCR) 5 –  , CD95-, and CXC chemokine receptor (CXCR) 
3  –  expressing CD4      T cells (  Fig. 1 D   and not depicted). 
  Figure 1.     Age-dependent differences in the clinical outcome of SIV infection. (A) Plasma vRNA levels through the course of SIVmac251 infection 
in infants (black symbols) and adults (gray symbols). Data points from each animal are shown using a different symbol; the same symbols are used in 
association with the same animals throughout this paper. For example, data from infant no. 37740 are consistently shown with     , whereas those from 
the rapidly progressing adult are shown with     . Two-way ANOVA analysis of values taken at weeks 2, 4, 8, and 12 suggests a signifi  cant effect of age 
group (P   0.017) and time point (P       0.0001). Bonferroni posttests show that the peak vRNA levels at 2 wk demonstrate the largest difference between 
the groups, as compared with differences at other time points, but the p-value for this post-hoc test is      0.05. (B) CD4      T cell counts during SIVmac251 
infection. (C) The ratio between CD4    /CD8     T cells in peripheral blood. The four continuous lines depict data from infants in this study, which were in-
fected at 6 wk of age. The dashed line shows composite data from 20 age-matched uninfected controls. Error bars show the standard error of the mean. 
(D) Frequency of CCR5      and  CD95     cells among CD3    CD4     cells of infected infant macaques and uninfected controls. (E) SIV-binding antibody titers 
among SIVmac251-infected infants and adults. Whole, disrupted SIV was used as the target antigen. (F) Weight gain among SIV-infected infants in 
this study. SIV infection at 6 wk of age is indicated with an arrow. Weight gain among normal male and female infants is also shown, with error bars 
indicating one standard deviation from the mean.     2682 T REG CELL SUPPRESSION OF SIV-SPECIFIC CD4      T CELLS | Hartigan-O  ’  Connor et al.
per day dropped during weeks 10  –  20. Nutritional supple-
ments, fl  uids, and antibiotics were provided in an attempt to 
support weight gain. Even with these interventions, three 
out of four infant monkeys had to be killed after     17 wk 
of infection because of weight loss, dehydration, and other 
clinical signs characteristic of simian AIDS (e.g., ulcerating 
mucosal infections). The association of progressively increas-
ing plasma viral loads with the development of simian AIDS 
suggested the possibility that rapid disease progression among 
infants was caused by poor immune control of virus. 
  As compared with adult T cells, infant T cells have a 
reduced capacity for cytokine production 
  The lymphocyte population in the peripheral blood of 
newborn macaques undergoes enormous phenotypic and 
functional changes during the fi  rst 3 mo of life (  32  ). Pheno-
typically, PBMCs at birth comprise     90% T cells and only 
10% B cells. Among the T cell population, the CD4/CD8 
T cell ratio is much higher in infants than in adults (  32, 33  ); 
however, as previously shown, the increased availability of 
potential SIV target cells does not correlate with an increased 
viral load (  33  ). In addition, many phenotypic markers used 
to defi  ne activation and disease progression in the T cells 
of HIV-infected adults are consistently expressed by healthy, 
observed in the rapidly progressing adult. The remaining 
infant (no. 37740) developed robust antibody responses that 
were sustained until necropsy at 5 mo. This data is consistent 
with previous reports showing lower anti-SIV antibody titers 
in infant compared with adult macaques (  31  ). 
  Rapid disease progression in infant macaques was further 
indicated by early (2 wk after infection) and frequent reports 
of diarrhea. In infants, diarrhea and associated weight loss 
(  Fig. 1 F  ) are important clinical symptoms because weight 
gain is critical for development. Although occasional out-
breaks of   Shigella  -related diarrhea (nosocomial or carried from 
dam) can be observed among neonates or infants, stool samples 
of the three infants with frequent reports of diarrhea tested 
negative for parasites (including   Giardia   and   Cryptosporidium  ), 
  Shigella  ,   Salmonella  ,   Aeromonas  ,   Yersinia  , and   Campylobacter  . 
Necropsy samples of intestine were also tested and proved 
negative for infectious causes of diarrhea. Therefore, diarrhea 
was most likely caused by SIV enterocolitis. In this context, 
it is noteworthy that monkey no. 37740 showed consistent 
weight gain throughout the fi  rst 20 wk of life and had only 
two reports of diarrhea. The other three infants, however, 
were repeatedly reported for diarrhea or plateau of weight 
gain. Furthermore, although these infants achieved normal 
weight gain during the fi  rst 10 wk of life, their weight gain 
  Figure 2.     Reduced capacity for cytokine production by infant T cells. (A) Representative fl  ow cytograms showing the distribution of CCR7 and 
CD45RA on unstimulated CD3      cells from infant (left) and adult (right) macaques. All data in A  –  D were produced using cells from uninfected animals. 
(B) The graph indicates the percentage of CD4      or  CD8     T cells that expressed CD69 after stimulation with medium or SEB. Whole blood was stimulated for 
6 h, then stained with surface antibodies before lysis and data collection. Horizontal bars represent means. (C) IFN-      production among CD3      cells  from 
infants (black symbols) and adults (gray symbols) after treatment with PMA/ionomycin for 6 h. Data for cytokine-producing naive (CD45RA    CCR7   )  and 
memory (CD45RA       CCR7    ) cells are shown. The data were produced by fi  rst gating on naive and memory cell populations and then assessing cytokine 
production within each subset. (D) IL-2 production among CD3      cells from infants and adults. Horizontal bars in C and D represent medians.     JEM VOL. 204, October 29, 2007 
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naive (CD45RA     CCR7     ) and memory (CD45RA        CCR7     ) 
T cells were substantially less likely than adult naive and 
memory T cells to produce IFN-      (  Fig. 2 C  ) or TNF-      (not 
depicted) after stimulation with SEB or PMA/ionomycin 
but equally likely to produce IL-2 (  Fig. 2 D  ). This tendency 
toward IL-2 production was particularly pronounced in naive 
cells. It should be noted that SEB was used over a range of 
200  –  1,000 ng and that the age-related diff  erences in cytokine 
production were found at all doses tested (unpublished data). 
To rule out the possibility that infant T cells could produce 
cytokines at levels comparable to adult T cells but with de-
layed kinetics, the kinetics of cytokine induction were also 
tested. Although the frequencies of IFN-       –   or TNF-       –  pro-
ducing cells from both infants and adults were increased at 12 
as compared with 6 h, production in infant T cells remained 
signifi  cantly less than that achieved by adult cells (P       0.0001; 
unpublished data). 
SIV-naive infant T cells. For example, almost all peripheral 
blood CD4      and CD8      T cells express CD38 throughout 
the fi  rst year of life (unpublished data). We hypothesized that 
the functional capacity of infant macaque T cells might also 
be substantially diff  erent from that of adult cells. 
  To address this hypothesis, infant and adult PBMCs were 
stimulated with the superantigen Staphylococcal enterotoxin 
B (SEB) or with PMA/ionomycin and assessed for cyto-
kine production by intracellular cytokine staining. Naive and 
memory T cell subpopulations were assessed separately be-
cause the vast majority of infant T cells are CD45RA     CCR7      
naive cells that might be expected to produce cytokine less 
readily (  Fig. 2 A  ).   We found that T cells from both infants 
and adults readily expressed the early activation marker CD69 
after treatment with SEB or PMA/ionomycin (15 or 95% 
of CD4      T cells, respectively, after 6 h;   Fig. 2 B   and not 
depicted), indicating successful stimulation. However, infant 
  Figure 3.     Infant macaque T reg cells are CD25     and CD127  low  . (A) Representative fl  ow cytograms show the distribution of CD25, CD127 (left), and 
FOXP3 (right) on infant CD3    CD4     cells from whole blood samples. All data in A  –  D were produced using cells from uninfected animals. (B) Distribution of 
CD25, CD127, and FoxP3 on adult CD3    CD4     cells from whole blood samples. (C) Expression of CD25 and CD127 on cells isolated by positive (left) or 
negative (right) selection on paramagnetic beads. The events shown are gated singlet lymphocytes expressing CD3 and CD4. 5       10 6   PMBCs  were 
processed. (D) Histograms show CFSE dilution in cultures stimulated with plate-bound anti-CD3 antibodies. CD25      and CD25-depleted cells were 
prepared according to the same methods described in   Fig. 2 C  . The unfractionated and CD25-depleted populations were labeled with CFSE. The unfrac-
tionated cell population (90,000 cells; top), CD25-depleted population alone (90,000 cells; middle), or CD25-depleted population with CD25      T  reg 
cells (90,000 and 30,000 cells, respectively; bottom) were incubated on plates coated with anti-CD3 antibodies for 5 d before analysis.     2684 T REG CELL SUPPRESSION OF SIV-SPECIFIC CD4      T CELLS | Hartigan-O  ’  Connor et al.
were used to isolate presumptive CD25      T reg cells for in 
vitro studies. 
  Our initial results (  Fig. 3  , compare A and B) suggested 
that T reg cells might be more abundant in the blood and tis-
sues of infant macaques than of adults. Indeed, we found that 
CD25      cells composed     10% of CD3     CD4      cells from 
infant blood but only     4% of CD3     CD4      cells from adult 
blood (  Fig. 4 A  ).   Using more stringent criteria to defi  ne the 
regulatory cell phenotype (CD25     CD127  low   or CD25     FoxP3     ) 
reduced the number of regulatory cells detected by fl  ow cy-
tometry but confi  rmed that T reg cells are more frequent 
among infant CD4      T cells (  Fig. 4 A  , second and third panels). 
Furthermore, because a larger fraction of infant T cells is CD4     , 
these diff  erences are even more pronounced when the values 
are expressed as a percentage of the CD3      population or as 
absolute numbers (  Fig. 4 A  ). 
  Because some CD25 expression is lost after freezing, the 
presence of T reg cells in frozen infant and adult lymph node 
cells was assessed using fl  ow cytometric staining for FoxP3. 
Axillary and retropharyngeal lymph nodes from uninfected 
infants at 4 wk of age contained a substantially larger fraction 
of FOXP3      cells among CD3      or CD4      T cells than adult 
nodes (  Fig. 4 B  ), mirroring the situation observed in whole 
blood samples. Adult and infant mesenteric lymph nodes 
  T reg cells are more abundant in the blood and tissues 
of infant than adult macaques 
  We and others have previously shown that T reg cells are 
abundant in the human fetus (  16  –  18  ). We speculated that T 
reg cells might also be abundant in newborn macaques and 
that their presence could influence the immune response 
to SIV. 
  To identify T reg cells in infant macaques, we examined 
expression of the markers CD25, CD127, and FOXP3, which 
are useful for the identification of T reg cells in mice, hu-
mans, and adult macaques (  28, 34  ). We found that virtually 
all CD4     CD25      cells in infant macaque blood and tissue 
are CD127  low   and that many are FoxP3      (  Fig. 3 A  ).   
CD4     CD25      cells of adults were similarly CD127  low  , al-
though a smaller fraction of these cells were FoxP3     . Because 
this result suggested that CD127 expression would not be 
necessary or useful for the diff  erentiation of T reg cells from 
activated T cells, as it is in humans, we isolated all CD25      
cells using paramagnetic beads and tested their suppressive 
capacity in vitro. The population of cells isolated using this 
method was 90% CD4     , 60% CD25     , and suppressive in vi-
tro, whereas negatively selected cells were CD25         and not 
suppressive in vitro (  Fig. 3, C and D  ; and not depicted). 
Therefore, for the remainder of this study, paramagnetic beads 
  Figure 4.     T reg cells are abundant in the blood and tissues of infant macaques. (A) T reg cell phenotypes in the blood of uninfected infant (1  –  5 wk), 
juvenile (18  –  30 mo), and adult (4  –  5 yr) macaques. Whole blood samples were taken from macaques at the indicated ages and stained for the markers 
indicated. Percentages shown (three left panels) are calculated as a fraction of the gated CD3    CD4     population. The absolute values in the far right panel 
were obtained by multiplying the percentages observed in fl  ow cytometric analysis by the absolute number of CD3    CD4     cells obtained in a complete 
blood count. The groups shown in each graph have signifi  cantly different means as tested by one-way ANOVA (P       0.001 in each case). The asterisks 
drawn between some groups indicate a signifi  cant difference in post-hoc testing (*, P       0.05; and **, P       0.01 using Dunn  ’  s multiple comparison test). 
Horizontal bars represent means. (B) FoxP3      cells detected fl  ow cytometrically in lymph node samples. Uninfected samples were frozen before analysis. 
Infected samples were harvested at necropsy (i.e., at different times after infection for each animal) and analyzed immediately. Among uninfected lymph 
node samples, two-way ANOVA shows a signifi  cant infl  uence of age (P       0.0001) and node (P       0.05). **, P       0.01 using Bonferroni posttests that sug-
gest a signifi  cant difference between adults and infants within axillary and retropharyngeal nodes. (C) FoxP3      cells detected by immunohistochemical 
staining of formalin-fi  xed, paraffi  n-embedded tissue. p-values were calculated using the Student  ’  s   t   test. Error bars represent means       SEM.   JEM VOL. 204, October 29, 2007 
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  Figure 5.     T reg cells of infants have greater suppressive activity than those of adults. (A) Representative fl  ow cytograms showing intracellular 
FOXP3 staining in uninfected adult (left) and infant (right) peripheral blood cells. Numbers represent the percentage of gated events found in each quadrant. 
(B) Percentages of CD3    CD4   CD25     cells from uninfected peripheral blood that were shown to express FOXP3 by intracellular staining and fl  ow cytometry. 
Horizontal bars represent means. (C) Suppression of cell division by CD25      T reg cells from infant and adult macaques isolated using paramagnetic beads. 
Data points indicate the division index achieved by CFSE-labeled cells in each sample as a percentage of the maximal value obtained in the CD25-depleted 
population. Cells were isolated from peripheral blood, purifi  ed using paramagnetic beads and columns, and stimulated for 5 d on anti-CD3  –  coated tissue 
culture plates. These data are representative of two experiments that tested a full range of T reg cell/responder ratios from infants and adults in parallel and 
are consistent with a much larger number of results testing suppression at a ratio of 1:3 and shown in D. (D) Results from a larger number of suppression 
assays performed on different days and testing suppression at a 1:3 ratio of T reg cells/responders. Horizontal bars represent means. (E) Adult and infant T reg 
cell populations purifi  ed by FACS. T reg cells represented      90% of the CD3    CD4     cells in sorted populations. The far right panel shows the intensity of FoxP3 
staining in aliquots of sorted adult and infant T reg cells (mean fl  uorescence intensity   513 and 831, respectively). (F) Results of suppression assays 
performed using regulatory cells purifi  ed by FACS from the blood of two uninfected infants and two uninfected adults. Because of limited cell numbers, these 
assays were performed using only 40,000 CD25-depleted responders. Responders were depleted of CD25      cells using paramagnetic beads. (G) Effect of T reg 
cell depletion on cytokine production by infant T cells in response to polyclonal stimuli. Aliquots of infant T cells were depleted of CD25      cells using paramag-
netic beads. Depleted or undepleted samples were then stimulated with PMA and ionomycin for 12 h, permeabilized, and stained with antibodies specifi  c for 
cytokines or cell-surface markers. The percentage of CD8      (far left graph) or CD4      (right three graphs) expressing various cytokine combinations (simultane-
ous IFN-      and TNF-     ) or individual cytokines (IFN-     , IL-2, or IL-4) in response to stimulation is shown. At least 12 samples are shown in each graph.    2686 T REG CELL SUPPRESSION OF SIV-SPECIFIC CD4      T CELLS | Hartigan-O  ’  Connor et al.
contained comparable numbers of FoxP3      cells, with a non-
signifi  cant trend toward observation of more FoxP3      cells in 
infant samples (  Fig. 4 B  ). Among infected animals, the frequen-
cies of CD25      cells in whole blood and fresh lymph node tissue 
at necropsy were signifi  cantly correlated (P   0.05; unpub-
lished data). Immunohistochemical staining for FoxP3      con-
fi  rmed these fl  ow cytometric results, demonstrating that the 
axillary and retropharyngeal lymph nodes of infants contain a 
larger number of FoxP3      cells than those of adults (  Fig. 4 C  ). 
  Because of limitations on tissue collection from young 
animals, we obtained SIV-infected infant lymph nodes only at 
necropsy. Comparison of these samples to adult nodes taken at 
necropsy revealed a nonsignifi  cant trend toward a higher fre-
quency of FoxP3      cells (  Fig. 4 B  ). However, adult and infant 
necropsies were performed at diff  erent times after infection, 
and it is unclear whether these samples are comparable to each 
other or indicative of conditions earlier in infection. At nec-
ropsy, both adult and infant nodes had a lower frequency of 
FoxP3  +   cells but not a lower frequency of CD25     CD127  low   
cells when compared with uninfected nodes (  Fig. 4 B   and 
not depicted). 
  T reg cells of infants are more suppressive in vitro 
than those of adults 
  Although neither infant nor adult macaque cells demon-
strated a discrete population of FoxP3      cells (  Fig. 5 A  ), such 
as is often found in human samples, expression of CD25 and 
expression of FOXP3 were correlated (  Fig. 3 A  ) such that 
more CD25      than CD25         cells were FoxP3     .   The propor-
tion of CD25      cells that was FoxP3     , however, diff  ered be-
tween adult and infant cells: only 20% of adult macaque 
CD25      T reg cells but      50% of infant macaque CD25      
T reg cells expressed detectable FoxP3 (  Fig. 5 B  ). Because 
the level of FOXP3 expression has been linked quantitatively 
to suppressive function in mouse cells (  35  ), this observation 
raised the possibility that infant macaque CD25      T reg cells 
might be more suppressive than their adult counterparts. 
However, there is evidence in the literature that FoxP3 ex-
pression cannot always be equated with regulatory function 
(  36  ). For this reason, we performed additional experiments 
aimed at testing the regulatory function of infant and adult 
T reg cells, defi  ned by surface phenotype, in vitro. 
  We tested the suppressive capacity of infant and adult 
macaque T reg cells in vitro at various responder/suppressor 
ratios. In replicate experiments, infant T reg cells were more 
suppressive than adult T reg cells at all ratios tested (  Fig. 5 C  ). 
This diff  erence was especially evident at 1:3 and 1:4 ratios of 
CD25      T reg cells/responders. We accordingly examined 
the degree of suppression achieved by adult and infant T reg 
cells at a 1:3 ratio in a larger number of suppression assays 
using samples from uninfected adults and infants. We found 
that the functional diff  erence between infant and adult T reg 
cells was consistent and statistically signifi  cant, with infant 
T reg cells suppressing an average of 75% of proliferation 
in vitro but adult T reg cells suppressing only 40%. (  Fig. 5 D  ). 
Because a larger percentage of infant PBMCs were CD25  +  , 
we considered the possibility that bead-based purifi  cation pro-
duced a more pure population of infant than adult T reg cells. 
To address this concern, nearly pure populations of adult and 
infant T reg cells were prepared by FACS (  Fig. 5 E  ). Infant T reg 
cells were more suppressive than adult T reg cells in this assay 
as well (  Fig. 5 F  ). 
  We performed depletion assays to determine whether 
T reg cells were the principal cause of poor IFN-      production 
among infant T cells exposed to polyclonal stimuli (  Fig. 2  ). 
Depletion of T reg cells from assays using stimulation with 
PMA/ionomycin had no consistent eff  ect on the production 
of IFN-      or TNF-      among CD8      T cells or on the produc-
tion of IFN-     , IL-2, or IL-4 among CD4      T cells (  Fig. 5 G   
and not depicted). 
  Higher numbers of T reg cells correlate with transient 
anti-SIV CD8     T cell responses 
  Given that both faster disease progression and a larger number 
of T reg cells were observed among infant macaques, we hy-
pothesized that T reg cells might suppress SIV-specifi  c CD8      
T cell responses in SIV-infected infants. This prediction was 
tested by performing cytokine fl  ow cytometry assays in the pres-
ence or absence of CD25      T reg cells (  Fig. 6, A and B  ).   
  Adult macaques were found to mount detectable CD8      
T cell responses to SIV p27 peptides throughout the course 
of infection (  Fig. 6 A  ). Peak SIV-specifi  c CD8      T cell re-
sponses were observed 1 wk after infection, coincident with 
peak viremia, and declined thereafter as vRNA levels also de-
clined (  Fig. 1 A  ). In contrast, although low SIV-specifi  c CD8      
T cell responses were detected in the peripheral blood of 
infant macaques at 2 and 4 wk after infection, they were not 
maintained thereafter. 
  Surprisingly, no diff  erence in CD8      T cell responses was 
observed after the depletion of T reg cells from either infant 
PBMCs, adult PBMCs, or adult lymph node cells (  Fig. 6 B  ). 
This fi  nding suggested that direct suppression by T reg cells 
is not the most important mechanism limiting CD8      T cell 
responses in either infant or adult macaques. Nevertheless, 
the two infants having the highest frequency of T reg cells 
at the time of infection produced no detectable anti-SIV 
responses among CD8      cells by 4 wk afterward (  Fig. 6 C  ), 
whereas the two infants with a lower frequency of T reg cells 
still had detectable responses at this time. 
  T cell activation levels were also evaluated in both age 
groups of animals. Despite harboring a larger population of 
T reg cells, infant animals displayed higher levels of T cell 
activation among CD4      and CD8      cells whether measured by 
Ki-67 or HLA-DR expression (  Fig. 6 D   and not depicted). 
In fact, we observed a trend, which did not reach statistical 
signifi  cance, toward more frequent expression of Ki-67 by 
infant than adult CD4      T cells. 
  Infant but not adult T reg cells suppress SIV-specifi  c 
CD4     T cell responses 
  Because transient CD8      T cell responses can be caused by 
the absence of CD4      T cell help (  10  ), we investigated the JEM VOL. 204, October 29, 2007 
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  The fi  nding of suppressed CD4      T cell responses among 
infants is consistent with the lower and transient antibody re-
sponses mounted by these animals (  Fig. 1 D  ). Although only 
whole SIV antibody responses were measured in this study, 
a previous study has shown that Gag antibody titers are 
reduced with the progression to simian AIDS and concurrent 
loss of CD4      T cells, whereas anti-Env antibodies develop 
relatively normally or increase (  31  ). We noted that one infant 
macaque (no. 37740) developed higher antibody titers, lower 
plasma vRNA levels, and apparently slower disease progres-
sion. This animal, like other infants, had poor SIV-specifi  c 
responses among undepleted CD4      T cells (  Fig. 7, A and B  ). 
The frequencies and absolute numbers of T reg cells were not 
signifi  cantly diff  erent in this animal than in other infants, al-
though we noted a trend toward fewer T reg cells during postin-
fection weeks 6  –  12 (  Fig. 7 E  ). However, this infant had the most 
robust response to SIV antigens among CD25-depleted cells of 
any animal, infant or adult (  Fig. 7, C and D  ). 
    DISCUSSION   
  The infl  uence of T reg cells on lentiviral disease progres-
sion remains unclear. In this study, we document not only 
a higher frequency but also a greater suppressive capacity of 
T reg cells among infant macaques as compared with adults. 
relationship between SIV-specifi  c CD4      T cells and CD25      
T reg cells in infected animals. Infected adult macaques 
mounted modest responses to SIV antigens among CD4      T 
cells, which were detected in both proliferation and cytokine 
fl  ow cytometry assays (  Fig. 7, A and B  , respectively).   Prolif-
erative responses increased gradually throughout the fi  rst 
4 mo, whereas responses detected by cytokine fl  ow cytometry 
peaked 1 wk after infection. Among adults, these responses 
were sustained throughout infection and were augmented 
only minimally by the depletion of T reg cells (  Fig. 7, C and D  ). 
Whole, undepleted PBMC samples from infected infants, 
on the other hand, demonstrated no or very low CD4      T 
cell responses to SIV throughout infection (  Fig. 7, A and B  ). 
Depletion of T reg cells from these samples, however, re-
vealed proliferative and IL-2 and IFN-      responses among 
CD4      T cells that were comparable to those observed 
in adults (  Fig. 7, C and D  , respectively). Depletion of T reg 
cells from infant lymph node samples taken at necropsy 
also revealed responses among CD4      T cells that were not 
observed in undepleted samples (unpublished data). Despite 
the apparent presence of T reg cells actively suppressing 
CD4 responses to SIV, few or no CD4      T cells producing 
IL-10 or TGF-      in response to SIV were detected (un-
published data). 
  Figure 6.     Transient CD8     T cell responses among infected infant macaques. (A) Percentage of CD3    CD8     T cells expressing IFN-      and  TNF-    
after exposure to p27 Gag peptides. Note that infant blood was not tested during the fi  rst week after infection because of limitations on blood collection. 
The symbols used for individual study animals are identical to those in   Fig. 1   and remain consistent in subsequent fi  gures. (B) Infl  uence of T reg cell de-
pletion on CD3    CD8     T cells expressing IFN-      and  TNF-    . The continuous lines in this graph represent averages of the lines shown in A. The dashed lines 
indicated the average response among study animals after depletion of CD25      T reg cells. (inset) the infl  uence of T reg cell depletion on CD8      T  cell 
responses within adult lymph nodes taken 4 and 8 wk after infection. (C) Correlation of the IFN-       TNF-        responses among CD8      cells at 4 wk after 
infection with the percentage of T reg cells present before infection. The slope of this line is signifi  cantly different from zero (P       0.05) when all ani-
mals are considered together but not when adults or infants are considered separately. (D) Intracellular Ki-67 expression among infant and adult T cells 
after infection with SIVmac251. Each line represents an average of four animals per study group. Error bars in B and D represent means       SEM.   2688 T REG CELL SUPPRESSION OF SIV-SPECIFIC CD4      T CELLS | Hartigan-O  ’  Connor et al.
not revealed by T reg cell depletion in vitro, such depletion 
did reveal sustained SIV-specifi  c CD4  +   T cell responses. Strik-
ingly, T reg cell suppression of SIV-specifi  c CD4  +   responses 
was only observed in infant, not in adult, macaques. Among 
infant macaques, the presence of a larger number of T reg 
We took advantage of this natural diff  erence to evaluate the 
impact of T reg cell function on SIV disease progression. In 
three out of four infant macaques, rapid disease progression 
was associated with low and transient CD4  +   and CD8  +   T cell 
responses. Although SIV-specifi  c CD8  +   T cell responses were 
  Figure 7.     Suppression of SIV-specifi  c CD4     T cells by infant but not adult T reg cells. (A) Cell division assessed by CFSE dilution among 
CD3    CD4     T cells. Purifi  ed PBMCs were labeled with CFSE and stimulated for 5 d by incubation of cultures with AT2-inactivated SIV. The percentages 
shown on the graph indicate the fraction of live CD3    CD4     T cells found below the primary, undivided peak of CFSE intensity. Background cell division 
observed after treatment of cultures with microvesicles has been subtracted. (B) Percentage of CD3    CD4     cells expressing IL-2 and IFN-      after  stimula-
tion with antigen, assessed by cytokine fl  ow cytometry. Note that infant blood was not tested during the fi  rst week after infection because of limitations on 
blood collection. (C) Infl  uence of T reg cell depletion on CD3    CD4     T cells that divide after exposure to AT2-SIV. The continuous lines in this graph repre-
sent averages of the four lines shown in panel A. The dashed lines indicate the average response among all four study animals after depletion of CD25      T 
reg cells. Finally, the dotted line indicates the response of an individual infant (no. 37740), which is discussed in Results. (D) Infl  uence of T reg cell deple-
tion on CD3    CD4     cells that express IL-2 and IFN-     . The continuous and dashed lines shown represent averages of all four study animals, as described in C. 
The dotted line indicates the response of infant no. 37740. (inset) The infl  uence of T reg cell depletion on CD4      T cell responses within adult lymph 
nodes taken 4 and 8 wk after infection. (E) T reg cells (CD3    CD4   CD25   CD127 low  ) in adult an infant peripheral blood after infection with SIV mac251. As in 
C and D, the continuous lines represent averages of four study animals, and the dotted line represents the number of cells found in infant no. 37740. 
Error bars in C, D, and E represent means       SEM.   JEM VOL. 204, October 29, 2007 
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  We did not observe in vitro suppression of CD4      or 
CD8      T cell responses by T reg cells in adult macaques. We 
do not know whether this suppression does not occur in vivo 
or whether it is simply more diffi   cult to detect in vitro be-
cause the T reg cells depleted from assays of adult cells are less 
suppressive. We fi  nd that T reg cell numbers vary widely be-
tween diff  erent adult humans and macaques (  28  ); possibly, 
suppression of CD4      T cell responses occurs only in adult 
macaques having the most T reg cells. 
  Our data suggest that infant T reg cells suppressed SIV-
specifi  c CD4      T cells but not   “  bystander  ”   CD4      T cells. The 
explanation for this difference might involve the respond-
ing CD4      T cells, the T reg cells, or both. With respect to 
responding CD4      T cells, SIV-specifi  c T cells and bystander 
T cells are being activated in vivo by diff  erent mechanisms. 
It is possible that these two mechanisms of T cell activa-
tion render the responding cells diff  erently sensitive to sup-
pression. With respect to the T reg cells themselves, the 
simplest explanation for diff  erential regulation is the out-
growth of SIV-specifi  c T reg cells. Despite clear suppression 
of anti-SIV responses, we did not detect SIV-specifi  c regula-
tory cells secreting IL-10 or TGF-      in response to SIV p27 
peptides or AT2-inactivated SIV. It is possible that SIV-specifi  c 
T reg cells were present but that the techniques used were 
not suffi     ciently sensitive to detect the cells. Alternatively, 
polyclonal T reg cells may have been activated and become 
suppressive in response to the infl  ammatory stimuli associated 
with infection. 
  In addition to active suppression by T reg cells, we found 
that the intrinsic functional ability of infant CD4      T cells to 
produce certain cytokines was reduced. Altered CD4      T cell 
function was still detected at 9 mo of age (unpublished data). 
Consistent with our fi  nding that IFN-      production by infant 
CD4      T cells is reduced, it has been documented that the 
IFN-      locus of human infant CD4      T cells is hypermethyl-
ated (  39  ). Thus, the kinetics of IFN-      induction could diff  er 
between infants and adults, and the time necessary to produce 
IFN-      in quantities suffi   cient to promote Th1 cell commit-
ment in infants might be extended. Interestingly, the SIV-
specifi  c CD4 as well as the CD8 T cell response was indeed 
much lower and of a transient nature when compared with 
the SIV-specifi  c T cell response observed in adult macaques. 
However, the in vitro depletion of T reg cells resulted in in 
vitro SIV-specifi  c CD4      T cell responses that were compara-
ble to those observed in adults. With the important caveat that 
the direct translation of in vitro fi  ndings to the in vivo situa-
tion and a direct comparison of results after polyclonal stimu-
lation versus antigen-specifi  c assays is problematic, it appears 
that the in vivo suppression of infant CD4      T cell function by 
T reg cells is more important than the reduced capacity of 
infant CD4      T cells to produce IFN-      in the prevention of 
eff  ective SIV T cell immunity in infants. 
  Infant macaques infected with SIVmac251 in this study 
experienced rapid disease progression, and three out of four 
were killed by 4 mo after infection. This fi  nding, together 
with our other published results (  40  ), suggests that the 
cells did not lead to reduced levels of T cell activation. These 
observations thus highlight a close association between T reg 
cell  –  mediated suppression of SIV-specifi  c CD4      T cell responses 
and rapid disease progression in infant macaques. 
  It is possible that a higher degree of T reg cell activity is 
responsible for key diff  erences between infant and adult 
immune systems, particularly the apparently lower reactivity 
of infant T cells to vaccines and infectious agents (  21, 22  ). 
Indeed, the current study documents an example of such low 
reactivity, in that SIV-infected infants mounted a CD8      T 
cell response that was of low intensity and short duration. 
A similar response to vaccination would be considered subopti-
mal, and our study suggests the possibility that interference 
with T reg cell function might augment the effi   cacy of vac-
cines in infants. Nonetheless, we also observed defi  ciencies in 
cytokine production among infant T cells that are indepen-
dent of T reg cell activity. Interventional studies that specifi  -
cally alter T reg cell function in infant macaques will be 
required before the impact of T reg cells on infant immune 
responses can be completely understood. 
  We noted that low-intensity and transient CD8      T cell 
responses among infants are associated with active suppres-
sion of CD4      T cells expressing IL-2 and IFN-     . We 
hypothesize that CD8      T cell responses in infants failed be-
cause of a lack of eff  ective support from CD4      T cells. Other 
groups have reported that chronic viral infections lead to ex-
haustion of the CD8      T cell response and have discovered 
that the exhausted CD8      cells are not deleted but remain in 
circulation, where the cells express programmed death 1 and 
possibly other inhibitory receptors that prevent eff  ector func-
tion (  37  ). This model could not be tested directly in this 
study because of the lack of tetramer reagents reactive to the 
MHC haplotypes of the animals. However, Matloubian et al. 
found that mice depleted of CD4      T cells demonstrate 
intense, permanent CD8      T cell exhaustion (  10  ), whereas 
Dittmer et al. showed that T reg cells lead to functional im-
pairment of CD8      T cells in Friend retrovirus infection (  38  ). 
Possibly, T reg cells render CD8  +   T cells vulnerable to ex-
haustion and programmed death 1 expression by depriving 
them of adequate CD4      T cell help. 
  Our data demonstrate consistent, active suppression of 
CD4      T cell responses in infants by CD25      T reg cells. Emu 
et al. found that multifunctional (IL-2     IFN-          ) CD4      T cell 
responses are more common in HIV-infected patients having 
apparently eff  ective anti-HIV immune responses: untreated 
elite controllers with viral loads      50 and treated patients 
with low viral loads despite the presence of drug-resistant vi-
rus (  9  ). Our data raise the possibility that these important ef-
fector cells are inhibited by T reg cells, which become 
increasingly prevalent among CD3     CD4      cells throughout 
the course of HIV disease. Other authors have reported that 
highly functional CD8      T cells are prevalent in nonprogres-
sors and are associated with low viral load (  8  ). Neither 
group examined the possibility that highly functional CD8  +   T 
cells and CD4      T cells are associated with each other in the 
same patients. 2690 T REG CELL SUPPRESSION OF SIV-SPECIFIC CD4      T CELLS | Hartigan-O  ’  Connor et al.
levels and function at 5 wk of age (  Fig. 2 A  ). Two of the adult animals 
received treatment with G-CSF 1 and 5 wk before infection as part of a sep-
arate study. G-CSF treatment did not aff  ect the number of T reg cells pres-
ent in peripheral blood before or after infection, the number of T reg cells in 
lymph nodes before or after infection, or the apparent progress of SIV disease 
relative to historical controls (unpublished data). 
  Virus load measurement.     Plasma RNA samples were analyzed for vRNA 
by a quantitative branched DNA assay (  43  ). Virus load in plasma samples is 
reported as log  10   vRNA copy numbers per milliliter of plasma. The detec-
tion limit of this assay is 125 vRNA copies. 
  Measurement of anti-SIV antibody titers.     Anti-SIV binding antibody 
titers in serum were measured as previously described (  44  ). Whole, disrupted 
SIV was used as the target antigen. The results of the anti-SIV antibody 
ELISAs are reported as the dilution of a sample that produced OD values 
above the cut-off   value. 
  Phenotypic characterization of lymphocyte populations.     50      l of 
whole blood from SIV-naive animals were stained with 3      l of each of the 
relevant antibodies (all obtained from BD Biosciences) to determine the fre-
quencies of CD3      T cells (clone SP34-2; BD Biosciences), CD4 and CD8      
T cells (clones L200 and RTP-8, respectively), and CD20      B cells (clone 
2H7). T cell subpopulations were further characterized by using the follow-
ing antibodies: CD62L (clone SK11), CD95 (DX2), CD27 (M-T271), 
CD28 (L293), CCR5 (3A9), and CXCR3 (1C6/CXCR3). The antibody 
for CD38 was obtained through the National Institutes of Health (NIH) 
Nonhuman Primate Reagent Resource (NPRR) from K. Reimann (Harvard 
University, Cambridge, MA). 
  Regulatory cell phenotyping was performed by staining 50-     l whole 
blood samples with antibodies reactive to FOXP3 (clone 206D, Pacifi  c blue 
labeled; BioLegend), CD4 (L200, AmCyan; NPRR), CD127 (hIL-7R  –  M21, 
PE; BD Biosciences), CD25 (MA-251, PE-Cy7; BD Biosciences), CD3 
(SP34-2, Alexa Fluor 700; BD Biosciences), and CD8 (allophycocyanin 
[APC]  –  Alexa Fluor 750, 3B5, Invitrogen). Staining for cell-surface markers 
was performed for 20 min at room temperature, the samples were lysed in 
FACS Lysing Buff  er (BD Biosciences), and cells were collected by centrifu-
gation. The collected cells were stained for intracellular FOXP3 according 
to the protocol provided by BioLegend. A second fl  ow cytometry panel 
was used to evaluate T cell activation. This panel included antibodies reac-
tive to CD3 (clone SP34-2, Pacifi  c blue labeled), CD4 (L200, AmCyan), 
CD38 (PE; NPRR), HLA-DR (Immu-357, ECD; Beckman Coulter), 
CD45RA (L48, PE-Cy7; BD Biosciences), CCR5 (3A9, APC; BD Biosci-
ences), CD8 (RPA-T8, Alexa Fluor 700; BD Biosciences), and CD27 
(O323, APC-Cy7; eBioscience). 
  In vitro stimulation of T cells with polyclonal stimuli.     100      l of 
whole blood was stimulated with varying doses of SEB (Toxin Technol-
ogies) or 50 ng/ml PMA and 1      g/ml ionomycin (Sigma-Aldrich). Cultures 
were stimulated for 6 h at 37  °  C, 5% CO  2   in the presence of brefeldin A at 
10      g/ml. At the end of the culture period, cells were stained according to 
the Alternative Protocol for Intracellular Cytokine Staining (according to 
BD Biosciences) using the following antibodies: CD3-PE-Cy7, CD4-PE, 
CD8  –  Pacifi  c blue, CD45RA-FITC (clone ALB11; Beckman-Coulter), 
CCR7-PE-Cy7 (3D12), IFN-       –  Alexa Fluor 700 (B27), and IL-2  –  APC 
(MQ1-17H12) or TNF-       –  APC (mAb11). A minimum of 150,000 events 
were acquired on a FACSAria (BD Biosciences). Data were analyzed using 
FlowJo software (Tree Star, Inc.). Samples from SIV-naive infant macaques 
were provided to K. Abel for analysis by N. Lerche (CNPRC, University of 
California, Davis, Davis, CA). 
  In vitro suppression assays.     250 ng anti-CD3 antibody in 50      l PBS 
(clone SP34-2) was added to wells of 96-well, U-bottom plates. The plates 
were incubated for at least 4 h and washed three times with PBS before use. 
SIVmac251 infection of infants can be an appropriate model 
for rapidly progressive HIV disease in perinatally infected hu-
mans. It is important to note, however, than most (70  –  80%) 
HIV-infected human infants do not progress rapidly in the 
absence of therapy (  19, 20  ). The infl  uence of T reg cells might 
well be diff  erent in the setting of slowly or rapidly progressive 
disease. For example, in rapidly progressive disease, eff  ector 
T cell responses that limit viral replication might be of utmost 
importance; under these conditions, a large population of 
T reg cells would accelerate progression. In slowly progressive 
disease, in contrast, suppression of bystander T cell activation 
by T reg cells could be benefi  cial. 
  This diff  erence may underlie the results found in the one 
infant macaque (no. 37740) that progressed more slowly after 
SIV infection. Furthermore, we noted that this infant had a 
very potent CD4     T cell response to SIV among T reg cell  –
  depleted populations, as well as robust SIV-binding antibody 
responses. We speculate that SIV-responsive CD4      T cells in 
this animal may have been able to provide help to B cells in 
vivo, despite their apparent lack of reactivity in the presence 
of T reg cells in vitro. 
  In conclusion, we fi  nd that infant macaques have a large 
number of highly suppressive T reg cells and that these cells di-
rectly inhibit the CD4      T cell response to SIV. Suppression of 
CD4      T cell responses was associated with a transient CD8      T 
cell response and limited antibody production. If these mecha-
nisms are at work in human patients, then T reg cell activity 
might partially explain the vulnerability of human infants to 
chronic viral infections. In the setting of HIV infection, eff  ec-
tive and persistent CD8      T cell responses are likely important 
for control. In hepatitis B virus infection, which proceeds to 
chronicity in 90% of neonates but only 5% of adults, sustained 
high-titer antibody production may be required for the elimi-
nation of the virus (  41  ). Further study will be required to de-
termine whether interference with the regulatory control of 
CD4      T cells can assist in control of these diseases. 
  MATERIALS AND METHODS 
  Animals.     All rhesus macaques were housed in accordance with the regula-
tions of the American Association for Assessment and Accreditation of Labo-
ratory Animal Care (AAALAC) at the California National Primate Research 
Center (CNPRC). Newborn rhesus macaques were born to female rhesus 
macaques of the CNPRC colony that are negative for HIV-2 (serology), 
SIV (serology), type D retrovirus (serology and PCR), and simian T cell 
lymphotropic virus type 1 (serology). All adult animals were also negative for 
HIV-2, SIV, type D retrovirus, and simian T cell lymphotropic virus type 1 
at study entry. SIV-infected animals were housed in the infectious housing 
unit in pairs of two animals per cage. SIV-naive infants were housed under 
comparable conditions, whereas SIV-naive adult monkeys were housed in 
outdoor corrals. Infant animals were 6 wk old at infection; adult animals 
were 3.4, 3.6, 3.6, and 3.7 yr old (approximately the age of reproductive 
maturity) (  42  ). Animal experiments were approved by the Institutional Ani-
mal Use and Care Committee of the University of California, Davis. 
  SIV inoculation.     SIV infection was performed by intravenous inoculation 
of 1 ml of 100 TCID  50   of SIVmac251. The virus stock was obtained form 
the ImmunoCore at the CNPRC (internal reference no. 06/04). Infant ma-
caques were 6 wk of age and adults were 3  –  5 yr of age at the time of SIV 
inoculation. The infant animals were the same animals tested for T reg cell JEM VOL. 204, October 29, 2007 
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TNF-     /IL-17/TGF-     ). The cells were fi  xed and permeabilized using 
Cytofi  x/Cytoperm (BD Biosciences), washed in Perm Buff  er (BD Biosciences), 
incubated with the appropriate antibodies in Perm Buff  er, washed, and 
resuspended in PBS containing 2% FBS and 1% paraformaldehyde. 
  SIV-specifi  c proliferation assays.     Unfractioned and CD25-depleted cell 
populations were prepared and labeled with CFSE as described in In vitro 
suppression assays. Stimuli including AT2-inactivated SIVmac239 and 70 ng/ml 
of control microvesicles were then added. The plates were incubated for 5 d 
before harvesting and analysis as described in In vitro suppression assays. 
  Statistical analysis.     Results were analyzed using ANOVA or the Student  ’  s 
  t   test using the GraphPad Prism and InStat software programs (version 4; 
GraphPad Software, Inc.). 
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